Clinical trials referenced in this document:
Documents that mention this clinical trial
Three Monthly Injections Versus One Initial Injection of Ranibizumab for the Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion: 12-Month Results of a Prospective Randomized Study
https://doi.org/10.1007/s40123-022-00588-7
Funding for this research was provided by:
National Natural Science Foundation of China (82101150, 82171078, 81870670)
Shanghai Hospital Development Center (SHDC2020CR2041B, SHDC2020CR5014-003)
Shanghai Sailing Program (21YF1405300)
Shanghai Science and Technology Development Foundation (20Y11911100, 18411965100)
Article History
Received: 30 August 2022
Accepted: 28 September 2022
First Online: 12 October 2022